Therapeutic Glaucoma

Big data drives opportunity for real-world evidence

Evidence-based medicine can lead to personalized care, better results for patients

Perioperative medications can eliminate postoperative drops after cataract surgery

Options can reduce the treatment burden for patients, leading to improved outcomes

Study results show that surgical system decreases IOP in patients with POAG

Investigators note the need for less medication over 12-month period

Glaucoma 360: Pharmaceuticals in the glaucoma industry

July 16, 2020

ICYMI: Ramin Valian, vice president of International Glaucoma, Reimbursement and Pipeline at Allergan, discusses glaucoma from a therapeutics/diagnostics and big data sets standpoint during the 2020 Glaucoma 360 meeting.

Next frontier in glaucoma: Beyond IOP-lowering treatments

July 15, 2020

Besides traditional medications, here are some of the many novel approaches to treat patients with glaucoma

Study targets topical medication adherence, visual field progression

July 08, 2020

Research is seeking benefits, options for open-angle glaucoma patients

Glaucoma treatment alternatives: Thinking outside the box

June 26, 2020

Treatment options may expand beyond surgery, medication, and lasers